Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atom Sarkar

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Biotechnology Progress|June 18, 2015
Glioma-astrocyte interactions on white matter tract-mimetic aligned electrospun nanofibersJoseph Grodecki, Aaron R Short, Jessica O Winter, et al.
Plos Genetics|March 8, 2021
miRNA-mediated loss of m6A increases nascent translation in glioblastomaJohn P Zepecki, David Karambizi, J Eduardo Fajardo, et al.
Cells|July 12, 2024
Adult Human Brain Tissue Cultures to Study NeuroHIVRachel Van Duyne, Elena Irollo, Angel Lin, et al.
Neuro-Oncology Practice|May 31, 2021
Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapyNa Tosha N Gatson, Mina Makary, Shane P Bross, et al.
Medical Oncology (Northwood, London, England)|September 4, 2010
Stereotactic radiosurgery alone for patients with 1-4 radioresistant brain metastasesSimon S Lo, James W Clarke, John C Grecula, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 6, 2018
Genetic susceptibility to cerebrovascular disease: A systematic reviewChristoph J Griessenauer, Sean Farrell, Atom Sarkar, et al.
American Journal of Clinical Oncology|August 5, 2009
Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasisJames W Clarke, Steven Register, John M McGregor, et al.
The Journal of Nutrition|February 3, 2012
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patientsViren Patel, Cameron Rink, Gayle M Gordillo, et al.
JCI Insight|April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's diseaseMartin Niethammer, Chris C Tang, Peter A LeWitt, et al.
The Lancet. Neurology|March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialPeter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biotechnology Progress|June 18, 2015
Glioma-astrocyte interactions on white matter tract-mimetic aligned electrospun nanofibersJoseph Grodecki, Aaron R Short, Jessica O Winter, et al.
Plos Genetics|March 8, 2021
miRNA-mediated loss of m6A increases nascent translation in glioblastomaJohn P Zepecki, David Karambizi, J Eduardo Fajardo, et al.
Cells|July 12, 2024
Adult Human Brain Tissue Cultures to Study NeuroHIVRachel Van Duyne, Elena Irollo, Angel Lin, et al.
Neuro-Oncology Practice|May 31, 2021
Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapyNa Tosha N Gatson, Mina Makary, Shane P Bross, et al.
Medical Oncology (Northwood, London, England)|September 4, 2010
Stereotactic radiosurgery alone for patients with 1-4 radioresistant brain metastasesSimon S Lo, James W Clarke, John C Grecula, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 6, 2018
Genetic susceptibility to cerebrovascular disease: A systematic reviewChristoph J Griessenauer, Sean Farrell, Atom Sarkar, et al.
American Journal of Clinical Oncology|August 5, 2009
Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasisJames W Clarke, Steven Register, John M McGregor, et al.
The Journal of Nutrition|February 3, 2012
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patientsViren Patel, Cameron Rink, Gayle M Gordillo, et al.
JCI Insight|April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's diseaseMartin Niethammer, Chris C Tang, Peter A LeWitt, et al.
The Lancet. Neurology|March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialPeter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
Pageof 3